Article Details
Retrieved on: 2024-09-30 02:57:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs has issued a 'buy' call on Neuland Laboratories, setting a target price of ₹12975 per share. The recent US FDA approval for ...
Article found on: www.businessupturn.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here